Skip to main content
Log in

Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran

  • Original Article
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

Abstract

The prenatal determination of the fetal Rh genotype could lead to a substantial reduction in the use of anti-D immunoglobulin and prevention of unnecessary exposure of pregnant women carrying RhD negative fetus. The aim of this study was fetal RHD genotyping through the analysis of cffDNA in plasma samples of RhD negative pregnant women by real-time PCR technique. In this experiment, 30 plasma samples were collected from RhD negative pregnant women. DNA were extracted and real-time PCR reactions were done by specific primers for RHD, SRY and beta-globin (GLO) genes. The Rh phenotypes of mothers and their babies were determined by agglutination method and specific anti-serums. From the 30 maternal plasma samples considered for SRY genotyping, 16 samples revealed the presence of the SRY gene. Regarding the fetal RHD genotyping, 26 samples were positive for RhD and 4 samples were negative. In all cases, the predicted RhD and SRY genotypes were in concordance with the serologically determined phenotypes. The sensitivity, specificity and precision of the fetal RHD and SRY genotyping test were calculated 100 % (p value <0.0005; K = 100 %). The present study confirms the precision of fetal RHD and SRY genotyping in maternal plasma by real-time PCR technique. This method helps RhD negative pregnant women about the appropriate use of anti-D immunoglobulin and also on the management and prevention of HDFN. However, superior and confirmatory studies are recommended before fetal RHD genotyping by real-time PCR is introduced as a non-invasive prenatal screening test.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Oliveira J, Osório N, Rocha J, Cruz B, Figueiredo J, Caseiro A, Valado A, Gabriel A, Mendes F (2012) Fetal RHD and RHCE genotyping in plasma of Rh negative pregnant women. Int J Biomed Lab Sci (IJBLS) 1.1(2):50–58

    Google Scholar 

  2. Van Kim CL, Colin Y, Cartron JP (2006) Rh proteins: key structural and functional components of the red cell membrane. Blood Rev 20(2):93–110. doi:10.1016/j.blre.2005.04.002

    Article  PubMed  Google Scholar 

  3. Flegel WA (2006) Molecular genetics of RH and its clinical application. Transfusion clinique et biologique: journal de la Societe francaise de transfusion sanguine 13(1–2):4–12. doi:10.1016/j.tracli.2006.02.011

    Article  CAS  Google Scholar 

  4. Daniels G (2013) Variants of RhD–current testing and clinical consequences. Br J Haematol 161(4):461–470. doi:10.1111/bjh.12275

    Article  PubMed  Google Scholar 

  5. Avent ND, Reid ME (2000) The Rh blood group system: a review. Blood 95(2):375–387

    CAS  PubMed  Google Scholar 

  6. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Kulovany E, Vlk R (2005) Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Fetal Diagn Ther 20(4):275–280. doi:10.1159/000085085

    Article  PubMed  Google Scholar 

  7. Wikman AT, Tiblad E, Karlsson A, Olsson ML, Westgren M, Reilly M (2012) Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 120(2 Pt 1):227–234. doi:10.1097/AOG.0b013e31825d33d9

    Article  PubMed  Google Scholar 

  8. Bowman JM, Chown B, Lewis M, Pollock JM (1978) Rh isoimmunization during pregnancy: antenatal prophylaxis. Can Med Assoc J 118(6):623–627

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Legler TJ, Muller SP, Haverkamp A, Grill S, Hahn S (2009) Prenatal RhD testing: a review of studies published from 2006 to 2008. Transfusion medicine and hemotherapy: offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie 36(3):189–198. doi:10.1159/000216580

    Article  Google Scholar 

  10. McIntosh RV, Welch AG (1995) Hepatitis C infection from anti-D immunoglobulin. Lancet 346(8971):372

    Article  PubMed  Google Scholar 

  11. Liumbruno GM, D’Alessandro A, Rea F, Piccinini V, Catalano L, Calizzani G, Pupella S, Grazzini G (2010) The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation. Blood Transfus 8(1):8–16. doi:10.2450/2009.0108-09

    PubMed  PubMed Central  Google Scholar 

  12. Kumpel BM (2008) Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn. Clin Exp Immunol 154(1):1–5. doi:10.1111/j.1365-2249.2008.03735.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. van der Schoot CE, Hahn S, Chitty LS (2008) Non-invasive prenatal diagnosis and determination of fetal Rh status. Semin fetal Neonatal Med 13(2):63–68. doi:10.1016/j.siny.2007.12.012

    Article  PubMed  Google Scholar 

  14. Amaral DR, Credidio DC, Pellegrino J Jr, Castilho L (2011) Fetal RHD genotyping by analysis of maternal plasma in a mixed population. J Clin Lab Anal 25(2):100–104. doi:10.1002/jcla.20440

    Article  CAS  PubMed  Google Scholar 

  15. Clausen FB (2014) Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat Diagn 34(5):409–415. doi:10.1002/pd.4326

    Article  PubMed  Google Scholar 

  16. Hill M, Finning K, Martin P, Hogg J, Meaney C, Norbury G, Daniels G, Chitty LS (2011) Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 80(1):68–75. doi:10.1111/j.1399-0004.2010.01533.x

    Article  CAS  PubMed  Google Scholar 

  17. Urbaniak SJ, Greiss MA (2000) RhD haemolytic disease of the fetus and the newborn. Blood Rev 14(1):44–61. doi:10.1054/blre.1999.0123

    Article  CAS  PubMed  Google Scholar 

  18. Daniels G, Finning K, Martin P, Summers J (2006) Fetal blood group genotyping: present and future. Ann N Y Acad Sci 1075:88–95. doi:10.1196/annals.1368.011

    Article  CAS  PubMed  Google Scholar 

  19. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, Wainscoat JS (1997) Presence of fetal DNA in maternal plasma and serum. Lancet (London, England) 350(9076):485–487. doi:10.1016/s0140-6736(97)02174-0

    Article  CAS  Google Scholar 

  20. Alberry M, Maddocks D, Jones M, Abdel Hadi M, Abdel-Fattah S, Avent N, Soothill PW (2007) Free fetal DNA in maternal plasma in anembryonic pregnancies: confirmation that the origin is the trophoblast. Prenat Diagn 27(5):415–418. doi:10.1002/pd.1700

    Article  CAS  PubMed  Google Scholar 

  21. Masuzaki H, Miura K, Yoshiura K, Yoshimura S, Niikawa N, Ishimaru T (2004) Detection of cell free placental DNA in maternal plasma: direct evidence from three cases of confined placental mosaicism. J Med Genet 41(4):289–292. doi:10.1136/jmg.2003.015784

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Flori E, Doray B, Gautier E, Kohler M, Ernault P, Flori J, Costa JM (2004) Circulating cell-free fetal DNA in maternal serum appears to originate from cyto- and syncytio-trophoblastic cells. Case report. Human Reprod 19(3):723–724. doi:10.1093/humrep/deh117

    Article  CAS  Google Scholar 

  23. Huppertz B, Kadyrov M, Kingdom JC (2006) Apoptosis and its role in the trophoblast. Am J Obstet Gynecol 195(1):29–39. doi:10.1016/j.ajog.2005.07.039

    Article  PubMed  Google Scholar 

  24. Birch L, English CA, O’Donoghue K, Barigye O, Fisk NM, Keer JT (2005) Accurate and robust quantification of circulating fetal and total DNA in maternal plasma from 5 to 41 weeks of gestation. Clin Chem 51(2):312–320. doi:10.1373/clinchem.2004.042713

    Article  CAS  PubMed  Google Scholar 

  25. Galbiati S, Smid M, Gambini D, Ferrari A, Restagno G, Viora E, Campogrande M, Bastonero S, Pagliano M, Calza S, Ferrari M, Cremonesi L (2005) Fetal DNA detection in maternal plasma throughout gestation. Hum Genet 117(2–3):243–248. doi:10.1007/s00439-005-1330-z

    Article  CAS  PubMed  Google Scholar 

  26. Yu SC, Lee SW, Jiang P, Leung TY, Chan KC, Chiu RW, Lo YM (2013) High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin Chem 59(8):1228–1237. doi:10.1373/clinchem.2013.203679

    Article  CAS  PubMed  Google Scholar 

  27. Machado IN, Castilho L, Pellegrino J Jr, Barini R (2006) Fetal rhd genotyping from maternal plasma in a population with a highly diverse ethnic background. Revista da Associação Médica Brasileira 52:232–235

    Article  PubMed  Google Scholar 

  28. Finning K, Martin P, Daniels G (2004) A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 1022:119–123. doi:10.1196/annals.1318.019

    Article  CAS  PubMed  Google Scholar 

  29. Dziegiel MH, On behalf of the Danish Network for Antenatal RHDS (2012) Noninvasive prenatal screening for RHD: the 1st national antenatal directed anti-D prophylaxis program—the Danish model or a guide to robust prediction of need of anti-D. ISBT Sci Ser 7(1):160–163. doi:10.1111/j.1751-2824.2012.01562.x

    Article  Google Scholar 

  30. Clausen FB, Damkjær MB, Dziegiel MH (2014) Noninvasive fetal RhD genotyping. Transfus Apheres Sci 50(2):154–162. doi:10.1016/j.transci.2014.02.008

    Article  Google Scholar 

  31. Daniels G, Finning K, Martin P, Massey E (2009) Noninvasive prenatal diagnosis of fetal blood group phenotypes: current practice and future prospects. Prenat Diagn 29(2):101–107. doi:10.1002/pd.2172

    Article  CAS  PubMed  Google Scholar 

  32. van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17(1):31–44. doi:10.1053/tmrv.2003.50001

    Article  PubMed  Google Scholar 

  33. Aykut A, Onay H, Sagol S, Gunduz C, Ozkinay F, Cogulu O (2013) Determination of fetal rhesus d status by maternal plasma DNA analysis. Balkan J Med Genet BJMG 16(2):33–38. doi:10.2478/bjmg-2013-0029

    CAS  PubMed  Google Scholar 

  34. Hromadnikova I, Vechetova L, Vesela K, Benesova B, Doucha J, Vlk R (2005) Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. J Histochem Cytochem Off J Histochem Soc 53(3):301–305. doi:10.1369/jhc.4A6372.2005

    Article  CAS  Google Scholar 

  35. Schmidt LC, Cabral AC, Faria MA, Monken F, Tarazona-Santos E, Martins ML (2014) Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population. Genet Mol Res GMR 13(1):799–805. doi:10.4238/2014.February.7.1

    Article  CAS  PubMed  Google Scholar 

  36. Randen I, Hauge R, Kjeldsen-Kragh J, Fagerhol MK (2003) Prenatal genotyping of RHD and SRY using maternal blood. Vox Sang 85(4):300–306

    Article  CAS  PubMed  Google Scholar 

  37. Wang XD, Wang BL, Ye SL, Liao YQ, Wang LF, He ZM (2009) Non-invasive foetal RHD genotyping via real-time PCR of foetal DNA from Chinese RhD-negative maternal plasma. Eur J Clin Invest 39(7):607–617. doi:10.1111/j.1365-2362.2009.02148.x

    Article  PubMed  Google Scholar 

  38. Chiu RW, Lo YM (2011) Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age. Semin Fetal Neonatal Med 16(2):88–93. doi:10.1016/j.siny.2010.10.003

    Article  PubMed  Google Scholar 

  39. Chan KC, Ding C, Gerovassili A, Yeung SW, Chiu RW, Leung TN, Lau TK, Chim SS, Chung GT, Nicolaides KH, Lo YM (2006) Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin Chem 52(12):2211–2218. doi:10.1373/clinchem.2006.074997

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the High Institute for Research and Education in Transfusion Medicine.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Azita Azarkeivan or Naser Amirizadeh.

Ethics declarations

Conflict of interest

The authors report no declarations of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahmadi, M.H., Hantuoshzadeh, S., Okhovat, M.A. et al. Fetal RHD Genotyping from Circulating Cell-Free Fetal DNA in Plasma of Rh Negative Pregnant Women in Iran. Indian J Hematol Blood Transfus 32, 447–453 (2016). https://doi.org/10.1007/s12288-015-0616-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-015-0616-0

Keywords

Navigation